2022
DOI: 10.1016/j.cell.2022.05.008
|View full text |Cite
|
Sign up to set email alerts
|

The Parkinson’s disease protein alpha-synuclein is a modulator of processing bodies and mRNA stability

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

4
76
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 70 publications
(81 citation statements)
references
References 139 publications
4
76
0
Order By: Relevance
“…Furthermore, it remains possible that oligomeric complexes may vary in composition. Indeed, mutations in α-synuclein oligomers result in abnormal interactions with RNA binding proteins and mitochondrial proteins, ultimately compromising the molecular machinery and leading to neurodegeneration. , Thus, the cellular functions of PACS-2 E209K in complex with different proteins could potentially be disrupted, analogous to α-synuclein mutants. To this end, PACS-2 E209K was already shown to favorably interact with histone modulators such as SIRT1 and HDAC1 along with the ion channel protein TRPV1 …”
Section: Resultsmentioning
confidence: 99%
“…Furthermore, it remains possible that oligomeric complexes may vary in composition. Indeed, mutations in α-synuclein oligomers result in abnormal interactions with RNA binding proteins and mitochondrial proteins, ultimately compromising the molecular machinery and leading to neurodegeneration. , Thus, the cellular functions of PACS-2 E209K in complex with different proteins could potentially be disrupted, analogous to α-synuclein mutants. To this end, PACS-2 E209K was already shown to favorably interact with histone modulators such as SIRT1 and HDAC1 along with the ion channel protein TRPV1 …”
Section: Resultsmentioning
confidence: 99%
“…In fact, we expect the local nucleic acid concentration to be higher in the nucleus, suggesting that the effects measured should be even stronger. Also, aS was shown to localize in the nucleus of the cells 76,77 , associated with nucleic acids 16,78 , nucleosomes 79 and processing bodies 46 , but no proof of direct and functional RNA binding effects on aggregation have been so far carried out. While Siegert and colleagues have shown RNA has little effect and can actually abrogate aS phase separation 47 , the molecular aspects of the effect of RNA on aS aggregation was not characterized.…”
Section: Discussionmentioning
confidence: 99%
“…aS has also been shown to undergo liquid-liquid phase separation and liquid-to-solid phase transition both in vitro 43 and in vivo 44 . It has been identified to be part of functional molecular condensates of the synaptic vesicle protein machinery 45 , processing bodies 46 and assemblies with protein tau 47 . Tau and aS have long been linked as "partners in pathology", with several studies showing the cross-seeding of aggregation [48][49][50] .…”
Section: Introductionmentioning
confidence: 99%
“…Since Hsp31 paralogs are multi-stress responding proteins with new emerging functions, detailed investigations may further decipher the mechanistic insights on how they provide genome protection. Moreover, Hsp31 paralogs also translocate into stress bodies and P-granules, which are recently associated with neurodegenerative diseases (Dudman & Qi, 2020; Hallacli et al, 2022; Miller-Fleming et al, 2014). Therefore, it is critical to characterize the significance of their translocation as it would unravel a broader understanding of DJ-1 family members, specifically in hDJ-1, whose loss of function leads to familial PD.…”
Section: Discussionmentioning
confidence: 99%